The merger brings together two leadingEMR and practice management platforms serving millions of patients in the U.S., strengthening innovation and amplifying market impact Cerbo and OptiMantra, two leading Electronic Medical Record (EMR) and practice management providers serving medical and wellness practices, today announced their merger. The combined company will unite their strengths to enhance care […]
A new nationwide survey conducted byAiForChurchLeaders.com and Exponential AI NEXT reveals pastors adopting AI at a pace few anticipated. 61% now use it weekly or daily, and 64% rely on it for sermon preparation. The same tools are steadily expanding into counseling prep, administrative workflows, and church operations. The findings signal a notable shift in
(NASDAQ:HWKN), ROSEVILLE, Minn., Dec. 03, 2025 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Redbird Chemical, Inc. (“Redbird”). Redbird distributes chemicals to its customers in eastern Texas within both the water treatment and industrial markets. “The acquisition of Redbird Chemical
(NASDAQ:BGLC), KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (NASDAQ: BGLC) (“BGLC” or the “Company”), a biotechnology company advancing precision diagnostics and gene-based technologies, today announced the formal completion of its strategic transaction with Fidelion Diagnostics Pte. Ltd. (“Fidelion”) and Tongshu Biotechnology. With the closing of the agreements, BGLC has
(Other OTC:CNTM),(OTC US:CNTM), MARLBOROUGH, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) — ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses powering the modern energy economy, today announced a current annual organic revenue run rate of $35 million, based on its existing operations and excluding revenue from its recently completed
(OTCQB:INNMF),(OTC US:INNMF),(AUST:ATX.AX), Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent for the FAK inhibitor narmafotinib The patent extends protection for narmafotinib to at least 2040 Melbourne, Australia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard(TM) GlobeNewswire December 03, 2025 KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (NASDAQ: BGLC) (“BGLC” or the “Company”), a biotechnology company advancing precision diagnostics and
ConnectM Announces $35 Million Annual Organic Revenue Run Rate and Returns to Positive Stockholders' Equity Company flips from a $50 million stockholders' deficit to $750K of positive equity GlobeNewswire December 03, 2025 MARLBOROUGH, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) — ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses
Key Narmafotinib Patent Granted in the U.S. GlobeNewswire December 03, 2025 Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent for the FAK inhibitor narmafotinib The patent extends protection for narmafotinib to at least 2040 Melbourne, Australia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Amplia
Forecast for Artificial Intelligence (AI) in Drones is Extraordinarily Robust with Market Projected to Triple in Value by 2030 GlobeNewswire December 03, 2025 MarketNewsUpdates News Commentary NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Artificial Intelligence (AI) is reportedly transforming drones and unmanned aerial vehicles from remote-controlled devices into autonomous, intelligent agents that have the